These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 21679006

  • 1. Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
    Klipping C, Duijkers I, Parke S, Mellinger U, Serrani M, Junge W.
    Drugs R D; 2011; 11(2):159-70. PubMed ID: 21679006
    [Abstract] [Full Text] [Related]

  • 2. Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
    Junge W, Mellinger U, Parke S, Serrani M.
    Clin Drug Investig; 2011; 31(8):573-584. PubMed ID: 21721593
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
    Spona J, Feichtinger W, Kindermann C, Schneider B, Mellinger U, Walter F, Moore C, Gräser T.
    Contraception; 1997 Aug; 56(2):67-75. PubMed ID: 9315414
    [Abstract] [Full Text] [Related]

  • 4. Effect of four oral contraceptives on hemostatic parameters.
    Wiegratz I, Lee JH, Kutschera E, Winkler UH, Kuhl H.
    Contraception; 2004 Aug; 70(2):97-106. PubMed ID: 15288212
    [Abstract] [Full Text] [Related]

  • 5. Investigation of the hemostatic effect of a transdermal patch containing 0.55 mg ethinyl estradiol and 2.1 mg gestodene compared with a monophasic oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel: an open-label, randomized, crossover study.
    Junge W, Heger-Mahn D, Trummer D, Merz M.
    Drugs R D; 2013 Sep; 13(3):223-33. PubMed ID: 24043457
    [Abstract] [Full Text] [Related]

  • 6. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
    Davis SR, Bitzer J, Giraldi A, Palacios S, Parke S, Serrani M, Mellinger U, Nappi RE.
    J Sex Med; 2013 Dec; 10(12):3069-79. PubMed ID: 24034466
    [Abstract] [Full Text] [Related]

  • 7. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
    Ahrendt HJ, Makalová D, Parke S, Mellinger U, Mansour D.
    Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
    [Abstract] [Full Text] [Related]

  • 8. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
    Wiegratz I, Stahlberg S, Manthey T, Sänger N, Mittmann K, Lange E, Mellinger U, Kuhl H.
    Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
    [Abstract] [Full Text] [Related]

  • 9. Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives.
    Bauerfeind A, von Stockum S, Boehnke T, Heinemann K.
    Obstet Gynecol; 2024 Mar 01; 143(3):431-434. PubMed ID: 38227942
    [Abstract] [Full Text] [Related]

  • 10. Estradiol valerate/dienogest: a novel combined oral contraceptive.
    Borgelt LM, Martell CW.
    Clin Ther; 2012 Jan 01; 34(1):37-55. PubMed ID: 22169052
    [Abstract] [Full Text] [Related]

  • 11. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE.
    Thromb Haemost; 2002 Feb 01; 87(2):199-205. PubMed ID: 11859850
    [Abstract] [Full Text] [Related]

  • 12. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR.
    Thromb Haemost; 2000 Jul 01; 84(1):4-8. PubMed ID: 10928461
    [Abstract] [Full Text] [Related]

  • 13. Estradiol valerate/dienogest: in oral contraception.
    Hoy SM, Scott LJ.
    Drugs; 2009 Aug 20; 69(12):1635-46. PubMed ID: 19678714
    [Abstract] [Full Text] [Related]

  • 14. Estradiol valerate/dienogest: a novel oral contraceptive.
    Whalen KL, Rose R.
    Ann Pharmacother; 2011 Oct 20; 45(10):1256-61. PubMed ID: 21917554
    [Abstract] [Full Text] [Related]

  • 15. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
    Raps M, Rosendaal F, Ballieux B, Rosing J, Thomassen S, Helmerhorst F, van Vliet H.
    J Thromb Haemost; 2013 May 20; 11(5):855-61. PubMed ID: 23410231
    [Abstract] [Full Text] [Related]

  • 16. Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables.
    Kluft C, Meijer P, LaGuardia KD, Fisher AC.
    Contraception; 2008 Feb 20; 77(2):77-83. PubMed ID: 18226669
    [Abstract] [Full Text] [Related]

  • 17. Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
    Lete I, Chabbert-Buffet N, Jamin C, Lello S, Lobo P, Nappi RE, Pintiaux A.
    Eur J Contracept Reprod Health Care; 2015 Feb 20; 20(5):329-43. PubMed ID: 26007631
    [Abstract] [Full Text] [Related]

  • 18. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.
    Prasad RN, Koh SC, Viegas OA, Ratnam SS.
    Clin Appl Thromb Hemost; 1999 Jan 20; 5(1):60-70. PubMed ID: 10725985
    [Abstract] [Full Text] [Related]

  • 19. Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial.
    Kangasniemi MH, Arffman RK, Joenväärä S, Haverinen A, Luiro K, Tohmola T, Renkonen R, Heikinheimo O, Tapanainen JS, Piltonen TT.
    Hum Reprod; 2023 Jan 05; 38(1):89-102. PubMed ID: 36416543
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
    Winkler UH, Schindler AE, Endrikat J, Düsterberg B.
    Contraception; 1996 Feb 05; 53(2):75-84. PubMed ID: 8838483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.